Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftware Circle Regulatory News (SFT)

Share Price Information for Software Circle (SFT)

Share Price is delayed by 15 minutes
Get Live Data
16.25    -0.55 (-3.27%)
Bid:
16.00
Ask:
16.50
Spread: 0.50 (3.125%)
Market Cap: £63.39m
SFT Live PriceLast checked at - London Stock Exchange

Intraday Software Circle Share Chart

Contract Gain

10 May 2006 08:00

Sinosoft Technology plc10 May 2006 10 May 2006 SINOSOFT TECHNOLOGY PLC CONTRACT GAIN Sinosoft Technology ("Sinosoft" or the "Company"), the China-based developer andprovider of software and IT solutions to Chinese regional and nationalgovernment agencies and export enterprises, announces today that it has enteredinto a distribution agreement with Beijing Capitek Co., Ltd ("Capitek"). Under the terms of the agreement, Capitek are licensed to sell up to 20,000copies of Sinosoft's Information Integration Software. The agreement, whichcommenced on 1 May 2006, is expected to generate up to US$450,000 in revenue forSinosoft. The software is an existing product from Sinosoft's portfolio ofsoftware solutions. Capitek specialises in the provision of network security software and is awholly owned subsidiary of Capitel Group, one of China's leading softwaretechnology businesses. Under the terms of the agreement, Capitek will utiliseits existing, extensive, network of sales channels to distribute Sinosoft'sInformation Integration Software across China. Miss Xin Yingmei, Chief Executive, commented: "We are delighted to have signedthis agreement with Capitek, a major brand in China. The distribution agreementwill provide Sinosoft with additional revenue and expands our geographical reachin China, increasing the number of provinces where our software products are inuse. Our ability to widen our presence in other provinces, without capitalintensive investment in infrastructure, is very encouraging and thecomplimentary nature of our product suite further enhances the benefit of suchan agreement." For further information, please contact: Tavistock Communications:Matt Ridsdale / Paul Dulieu 020 7920 3150 Westhouse SecuritiesTim Metcalfe / Richard Baty 020 7601 6100 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Jun 20083:22 pmRNSHolding(s) in Company
12th Jun 20084:37 pmRNSDirector/PDMR Shareholding
9th Jun 200812:50 pmRNSAGM Statement
30th May 200810:17 amRNSLetter to Shareholders
13th May 20086:00 amRNSDividend Declaration
28th Apr 200811:29 amRNSDirector/PDMR Shareholding
28th Apr 20087:09 amRNSPreliminary Results
25th Apr 20087:01 amRNSNotice of Results
16th Jan 20087:09 amRNSTrading Statement
9th Jan 20085:14 pmRNSHolding(s) in Company
13th Dec 20073:16 pmRNSHolding(s) in Company
15th Oct 200712:29 pmRNSDirectorate Change
25th Sep 20077:02 amRNSInterim Results
15th Aug 200710:04 amRNSAIM Rule 26
29th Jun 200710:03 amRNSTrading Statement
15th May 20078:59 amRNSDirectorate Change
15th May 20078:58 amRNSDirectorate Change
2nd May 200712:44 pmRNSAGM Statement
3rd Apr 200711:20 amRNSAnnual Report and Accounts
6th Mar 20077:04 amRNSFinal Results
21st Feb 200711:38 amRNSHolding(s) in Company
21st Dec 20067:00 amRNSTrading Statement
18th Dec 20061:04 pmRNSSales Contract
14th Dec 200610:32 amRNSTotal Voting Rights
21st Nov 20061:05 pmRNSNew Cooperation Agreement
21st Nov 200612:51 pmRNSUpdate on SAT Contract
11th Oct 20067:00 amRNSDirector/PDMR Shareholding
18th Sep 200611:13 amRNSInterim Results
16th Aug 200611:29 amRNSProgress on Contracts
19th Jun 200611:56 amRNSHolding(s) in Company
12th May 20068:14 amRNSHolding(s) in Company
10th May 20068:00 amRNSContract Gain
11th Apr 20067:01 amRNSFinal Results
6th Apr 200612:15 pmRNSNotice of Results
21st Mar 200612:55 pmRNSHolding(s) in Company
13th Mar 20062:28 pmRNSHolding(s) in Company
9th Mar 20065:44 pmRNSHolding(s) in Company
6th Mar 20067:00 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.